Caleb R Glassman

Title: The Innovations of Caleb R. Glassman

Introduction

Caleb R. Glassman is an accomplished inventor based in Palo Alto, California. He has made significant contributions to the field of biotechnology, particularly in the development of interleukin-2 muteins. His work has implications for treating autoimmune diseases and conditions.

Latest Patents

Caleb holds a patent for "Partial agonists of interleukin-2." This patent includes human interleukin-2 (IL-2) muteins or variants that exhibit a decreased binding capacity for IL-2Rγ. These IL-2 muteins serve as partial agonists in applications where the reduction or inhibition of IL-2 and/or IL-15 functions is beneficial. The patent also covers nucleic acids encoding these IL-2 muteins, methods for their production, and pharmaceutical compositions that incorporate them.

Career Highlights

Caleb is affiliated with Leland Stanford Junior University, where he continues to advance his research in immunology and biotechnology. His innovative work has positioned him as a key figure in the development of therapeutic strategies for autoimmune disorders.

Collaborations

Caleb collaborates with notable colleagues, including Kenan Christopher Garcia and Sonia S. Majri. Their combined expertise enhances the research efforts at their institution.

Conclusion

Caleb R. Glassman exemplifies the spirit of innovation in biotechnology through his groundbreaking work on interleukin-2 muteins. His contributions are paving the way for new treatments in the medical field.